Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07055919

Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).

A Prospective, Multicenter, Stratified Randomized Controlled, Non-Inferiority Clinical Trial to Evaluate the Safety and Efficacy of the Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
112 (estimated)
Sponsor
Xiamen Cardiovascular Hospital, Xiamen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial aims to evaluate the safety and efficacy of the Structural Heart Surgery Assist System in assisting TEER for patients with moderate-to-severe or greater degenerative or functional mitral regurgitation (MR ≥3+). A prospective, multicenter, stratified randomized controlled design with non-inferiority comparison will be used. The experimental group will utilize the Structural Heart Surgery Assist System, while the control group will undergo manual TEER (e.g., MitraClip G4).

Conditions

Interventions

TypeNameDescription
DEVICEStructural Heart Surgery Assist SystemFollowing femoral venous access and transseptal puncture, the steerable guide catheter and transcatheter mitral valve clip system are inserted and mounted onto the Structural Heart Surgery Assist System. The surgeon manipulates the joystick and controls on the operator console, guided by real-time animations on the human-machine interface that confirm the direction and range of device motion. Under fluoroscopic (DSA) and echocardiographic guidance, the system assists in performing edge-to-edge mitral valve repair. The procedure achieves regurgitation reduction by either creating a double-orifice configuration (A2/P2 segments) or approximating the opposing leaflets at the A1/P1 or A3/P3 regions.
DEVICEManual MitraClip G4Manual MitraClip G4

Timeline

Start date
2025-03-22
Primary completion
2026-03-22
Completion
2026-04-22
First posted
2025-07-09
Last updated
2025-07-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07055919. Inclusion in this directory is not an endorsement.